10:03 AM EST - Aeterna Zentaris Inc. : announced the signing of an exclusive development, commercialization and licensing agreement for the development, registration and marketing of perifosine, Aeterna Zentaris' lead anti-cancer compound, for Japan. Aeterna Zentaris Inc.
shares T.AEZ are trading up $0.23 at $1.95.
